NASDAQ | TSX: ACB
Available at launch exclusively to Aurora's
veteran patients, new products span THC, CBD and CBG offerings
to meet the discerning taste, experience and product variety
patients seek
EDMONTON, AB, Jan. 24,
2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:
ACB) (TSX: ACB), the Canadian-based leading global medical cannabis
company, announces the launch of three new cannabis-infused
beverages, available exclusively at first to veteran patients.
Designed to deliver on taste, potency and choice, the introduction
of beverages is in response to the needs of patients looking for
alternative forms of cannabis to support their wellbeing. Three
cannabis-infused products produced by Vacay and Versus, and
available in three fruity flavours: Neon Rush, Strawberry Pineapple
Tropical Fizz and Pineapple Coconut Fizz can be purchased at Aurora
Medical.
"As the largest Canadian medical cannabis company with a deep
commitment to our veteran patients, we take great care in listening
to their needs and responding with products that support their
wellbeing," said Mike Jones, Senior
Vice President of Medical Sales at Aurora. "We are excited to
introduce a new product category that our patients can enjoy
easily. Our team is passionate about expanding our product offering
further and ensuring all patients can rely on Aurora for their
medical cannabis."
The new cannabis infused beverages are available in 355ml cans
and are crafted with SōRSE® emulsion technology for little to no
cannabis aroma or taste. Veteran patients can order any mix of
flavours up to four cans of each product per order for a total of
12 cans. The beverages are launching in three unique flavour
SKUs:
- VACAY's Strawberry Pineapple Tropical Soda: a 3:1 hybrid
beverage with 2-3mg of THC and 6.4-8.6mg of CBD. This Strawberry
Pineapple Tropical Soda delivers a refreshing blend of sweet, tart,
and summery flavours with crisp carbonation in every sip.
- VACAY Pineapple Coconut Tropical Fizz 3:1: a hybrid
carbonated drink with 2-3mg THC and 6.4mg-8.6mg CBD, this beverage
will transport your tastebuds to island paradise with a burst of
tangy pineapple flavours mixed with creamy undernotes of
coconut.
- VERSUS Neon Rush: a delicious hybrid carbonated
beverage infused with lemon-lime flavour and 30mg of caffeine
featuring 8.5-10mg THC and 1mg CBD.
For more information visit Aurora Medical.
About Aurora:
Aurora is opening the world to cannabis, serving both the medical
and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global
cannabis, dedicated to helping people improve their lives. The
Company's adult-use brand portfolio includes Aurora
Drift, San Rafael '71, Daily
Special, Being and Greybeard. Medical
cannabis brands include MedReleaf, CanniMed, Aurora and
Whistler Medical Marijuana Co, as well as international brands,
Pedanios, Bidiol and CraftPlant. Aurora also has a controlling
interest in Bevo Farms Ltd., North
America's leading supplier of propagated agricultural plants.
Driven by science and innovation, and with a focus on high-quality
cannabis products, Aurora's brands continue to break through as
industry leaders in the medical, performance, wellness, and adult
recreational markets wherever they are launched. Learn more
at www.auroramj.com and follow us on LinkedIn
and X.
Aurora's common shares trade on the NASDAQ and TSX under the
symbol "ACB".
Forward-looking
Information
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news
release include, but are not limited to, statements with respect to
the launch and availability of a new product and product category
into the Canadian medical market and the future expansion of
product offerings.
These forward-looking statements are only predictions. Forward
looking information or statements contained in this news release
have been developed based on assumptions management considers to be
reasonable. Material factors or assumptions involved in developing
forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from
market research and industry analysis and on assumptions based on
data and knowledge of this industry which the Company believes to
be reasonable. Forward-looking statements are subject to a variety
of risks, uncertainties and other factors that management believes
to be relevant and reasonable in the circumstances could cause
actual events, results, level of activity, performance, prospects,
opportunities or achievements to differ materially from those
projected in the forward-looking statements. These risks include,
but are not limited to, the ability to retain key personnel, the
ability to continue investing in infrastructure to support growth,
the ability to obtain financing on acceptable terms, the continued
quality of our products, customer experience and retention, the
development of third party government and non-government consumer
sales channels, management's estimates of consumer demand in
Canada and in jurisdictions where
the Company exports, expectations of future results and expenses,
the risk of successful integration of acquired business and
operations, management's estimation that SG&A will grow
only in proportion of revenue growth, the ability to expand and
maintain distribution capabilities, the impact of competition, the
general impact of financial market conditions, the yield from
cannabis growing operations, product demand, changes in prices of
required commodities, competition, and the possibility for changes
in laws, rules, and regulations in the industry, epidemics,
pandemics or other public health crises, including the current
outbreak of COVID-19, and other risks, uncertainties and
factors set out under the heading "Risk Factors" in the Company's
annual information form dated June 14, 2023 (the "AIF")
and filed with Canadian securities regulators available on the
Company's issuer profile on SEDAR
at www.sedar.com and filed with and available on
the SEC's website at www.sec.gov. The Company
cautions that the list of risks, uncertainties and other factors
described in the AIF is not exhaustive and other factors could also
adversely affect its results. Readers are urged to consider the
risks, uncertainties and assumptions carefully in evaluating the
forward-looking statements and are cautioned not to place undue
reliance on such information. The Company is under no obligation,
and expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable securities law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aurora-unveils-innovative-cannabis-infused-ready-to-drink-beverage-in-latest-medical-product-launch-302042925.html
SOURCE Aurora Cannabis Inc.